3.52 USD
▲+0.02+0.57%
盘后 3.59 +1.99%
2026-11-20
市值
$50.69M
市盈率
—
EPS
-2.24
股息率
—
52 周区间
3.02 – 10.84
成交量
144.07K
Beta
1.06
目标价
32.20
52W 低 3.0252W 高 10.84
价格走势
公司简介
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company’s lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinde...